Estelle Thébaud

1.6k total citations
53 papers, 647 citations indexed

About

Estelle Thébaud is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Estelle Thébaud has authored 53 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Neurology and 17 papers in Molecular Biology. Recurrent topics in Estelle Thébaud's work include Neuroblastoma Research and Treatments (17 papers), Sarcoma Diagnosis and Treatment (11 papers) and Renal and related cancers (8 papers). Estelle Thébaud is often cited by papers focused on Neuroblastoma Research and Treatments (17 papers), Sarcoma Diagnosis and Treatment (11 papers) and Renal and related cancers (8 papers). Estelle Thébaud collaborates with scholars based in France, Italy and United Kingdom. Estelle Thébaud's co-authors include Daniel Orbach, Michela Casanova, Andrea Ferrari, Annie Rey, Marcelo Scopinaro, Modesto Carli, Giovanni Cecchetto, Gianni Bisogno, O. Oberlin and Nadège Corradini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Estelle Thébaud

52 papers receiving 633 citations

Peers

Countries citing papers authored by Estelle Thébaud

Since Specialization

Citations

This map shows the geographic impact of Estelle Thébaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Thébaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Thébaud more than expected).

Fields of papers citing papers by Estelle Thébaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle Thébaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Thébaud. The network helps show where Estelle Thébaud may publish in the future.

Co-authorship network of co-authors of Estelle Thébaud

This figure shows the co-authorship network connecting the top 25 collaborators of Estelle Thébaud. A scholar is included among the top collaborators of Estelle Thébaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estelle Thébaud. Estelle Thébaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study 2025 ·Pediatric Blood & Cancer ·Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher, Marion Gambart, (unknown), Arnaud Petit, (unknown), Estelle Thébaud, Yves Réguerre, (unknown), (unknown), Anne Sophie Defachelles, Pablo Berlanga	0
2	Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord‐stromal tumors. Results of the TGM13 National Registry 2024 ·Pediatric Blood & Cancer ·(unknown), (unknown), Daniel Orbach, Hélène Sudour‐Bonnange, Cécile Verite, Angélique Rome, (unknown), Estelle Thébaud, Frédéric Hameury, Frédérique Dijoud, Sylvie Chabaud, (unknown), Brice Fresneau, Cécile Faure‐Conter	1
3	Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS 2024 ·European Journal of Cancer ·(unknown), (unknown), Nadège Corradini, Nicolás André, Estelle Thébaud, Marion Gambart, Anne Sophie Defachelles, Natacha Entz‐Werlé, Pascal Chastagner, Émilie De Carli, Stéphane Ducassou, Judith Landman‐Parker, Tiphaine Adam de Beaumais, (unknown), Stefan Michiels, Gilles Vassal, Dominique Valteau‐Couanet, Birgit Geoerger, (unknown)	1
4	1755P Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial 2024 ·Annals of Oncology ·Valérie Laurence, (unknown), Sylvain Dureau, Nina Jehanno, Gaëlle Pierron, (unknown), (unknown), (unknown), Cyril Lervat, Sophie Taque, (unknown), (unknown), (unknown), (unknown), Laure Saumet, Cécile Verite, (unknown), Estelle Thébaud, Mehdi Brahmi, (unknown)	1
5	Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology—Renal Tumor Study Group (SIOP‐RTSG)‐related retrospective descriptive study 2023 ·Cancer Medicine ·(unknown), (unknown), Filippo Spreafico, Barbara Selle, Estelle Thébaud, Tanzina Chowdhury, Jesper Brok, (unknown), (unknown), Gema Ramírez, (unknown), Heidi Segers, Dimitrios Doganis, Annalisa Serra, (unknown), Norbert Graf, Arnauld Verschuur, Godelieve A.M. Tytgat, Marry M. van den Heuvel‐Eibrink	2
6	Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol 2022 ·Pediatric Blood & Cancer ·Cécile Faure‐Conter, Daniel Orbach, Hélène Sudour‐Bonnange, Cécile Verite, L Mansuy, Angélique Rome, (unknown), Estelle Thébaud, Marleen Renard, Frédéric Hameury, Aude Fléchon, Ellen Blanc, Frédérique Dijoud, Brice Fresneau, Sylvie Chabaud	3
7	Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium 2021 ·European Journal of Cancer ·Claudia Pasqualini, (unknown), (unknown), Lydie Cassard, Nicolás André, (unknown), Jean‐Yves Scoazec, Antonin Marchais, (unknown), Lisa Boselli, Jonathan Grivel, Isabelle Aerts, Estelle Thébaud, Xavier Paolettí, Véronique Minard‐Colin, Gilles Vassal, Birgit Geoerger	36
8	Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations 2021 ·European Journal of Cancer ·(unknown), Véronique Minard‐Colin, Nadège Corradini, Guy Leverger, Estelle Thébaud, Angélique Rome, Stéphanie Proust, Aude Marie‐Cardine, Anne Sophie Defachelles, Sabine Sarnacki, Pascale Philippe‐Chomette, Olivier Delattre, Julien Masliah‐Planchon, Brigitte Lacour, Andrea Ferrari, Bernadette Brennan, Daniel Orbach, Franck Bourdeaut	11
9	Unresectable thoracic neuroblastic tumors: Changes in image‐defined risk factors after chemotherapy and impact on surgical management 2021 ·Pediatric Blood & Cancer ·Xavier Delforge, (unknown), Anne Sophie Defachelles, Aurore Haffreingue, Julien Rod, (unknown), (unknown), (unknown), (unknown), Alexis Arnaud, (unknown), Estelle Thébaud, Marc‐David Leclair	7
10	Disorder of sex development with germ cell tumors: Which is uncovered first? 2020 ·Pediatric Blood & Cancer ·Cécile Faure‐Conter, Daniel Orbach, Brice Fresneau, Cécile Verite, (unknown), Estelle Thébaud, Maryline Poirée, Sandrine Thouvenin, Claire Pluchart, Pierre‐Yves Mure, Frédérique Dijoud, Yves Morel	6
11	Environmental exposures related to parental habits in the perinatal period and the risk of Wilms' tumor in children 2020 ·Cancer Epidemiology ·(unknown), (unknown), Gudrun Schleiermacher, Claudia Pasqualini, Cécile Boulanger, Estelle Thébaud, Virginie Gandemer, Isabelle Pellier, Arnauld Verschuur, Hélène Sudour‐Bonnange, Aurore Coulomb L’Herminé, (unknown), (unknown), Christophe Bergeron, Laurent Orsi, Brigitte Lacour, Jacqueline Clavel	9
12	Maternal and perinatal characteristics, congenital malformations and the risk of wilms tumor: the ESTELLE study 2020 ·Cancer Causes & Control ·(unknown), (unknown), Gudrun Schleiermacher, Dominique Valteau‐Couanet, Anne‐Isabelle Bertozzi, Estelle Thébaud, Virginie Gandemer, Isabelle Pellier, Arnauld Verschuur, (unknown), (unknown), Christophe Bergeron, Laurent Orsi, Brigitte Lacour, Jacqueline Clavel	6
13	Utilisation des médecines complémentaires et alternatives chez l’enfant et l’adolescent atteint de cancer : une pratique fréquente 2019 ·Bulletin du Cancer ·(unknown), É. Seigneur, Christèle Gras‐Le Guen, Daniel Orbach, Estelle Thébaud	7
14	Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside 2017 ·OncoImmunology ·(unknown), (unknown), Sophie Fougeray, Ali El Roz, Julien Fleurence, Joëlle Véziers, Marc‐David Leclair, Estelle Thébaud, François Paris, Stéphane Birklé	11
15	Maternal use of household pesticides during pregnancy and risk of neuroblastoma in offspring. A pooled analysis of the ESTELLE and ESCALE French studies (SFCE) 2017 ·Cancer Causes & Control ·(unknown), Helen D. Bailey, Brigitte Lacour, Dominique Valteau‐Couanet, Jean Michon, Christophe Bergeron, Hélène Boutroux, Anne Sophie Defachelles, Marion Gambart, Nicolas Sirvent, Estelle Thébaud, Stéphane Ducassou, Laurent Orsi, Jacqueline Clavel	14
16	Large Cell Neuroendocrine Carcinoma of the Nasopharynx 2015 ·Journal of Pediatric Hematology/Oncology ·(unknown), Estelle Thébaud, Madeleine Joubert, Karine Renaudin, (unknown), Marie‐Françoise Heymann	6
17	Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN 2014 ·PLoS ONE ·Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, Jérôme Couturier, Isabelle Janoueix‐Lerosey, Valérie Combaret, Véronique Mosseri, Estelle Thébaud, Marion Gambart, Dominique Plantaz, Aurélien Marabelle, Carole Coze, Xavier Rialland, (unknown), Eve Lapouble, Paul Fréneaux, Michel Peuchmaur, Jean Michon, Olivier Delattre, Gudrun Schleiermacher	15
18	Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends 2012 ·Pediatric Blood & Cancer ·(unknown), Nicolás André, Estelle Thébaud, Odile Minckes, Xavier Rialland, Nadège Corradini, Isabelle Aerts, (unknown), Franck Bourdeaut, Pierre Leblond, (unknown)	43
19	Predicting the risk of severe bacterial infection in children with chemotherapy‐induced febrile neutropenia 2010 ·Pediatric Blood & Cancer ·E Macher, François Dubos, Nathalie Garnier, (unknown), Eva de Berranger, Estelle Thébaud, Françoise Mazingue, Pierre Leblond, A. Martinot	43
20	Use of Conventional Fractionation With Cyberknife in Children: A Report of 5 Cases 2010 ·Journal of Pediatric Hematology/Oncology ·(unknown), S. Dewas, Bernard Coche‐Dequeant, Pierre Leblond, Anne Sophie Defachelles, Estelle Thébaud, T. Lacornerie, Éric Lartigau	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact